Lambert-Eaton News Forums Forums In the News Firdapse Oral Therapy Expected to Become LEMS’ Treatment of Choice, Review Says

  • Firdapse Oral Therapy Expected to Become LEMS’ Treatment of Choice, Review Says

    Posted by Forum Moderator on January 4, 2020 at 12:59 pm

    Scientists believe Firdapse (amifampridine phosphate) will soon become first-line management therapy for Lambert-Eaton myasthenic syndrome. Read more here.

    What do you think of this prediction?

    Forum Moderator replied 4 years, 5 months ago 0 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.